Pharmacologic Therapy for Gastroesophageal Reflux Disease in Children - Cochrane for ...
Sep 1, 2015 - Among infants younger than 12 months diagnosed with GERD, weak evidence supports the use of proton pump inhibitors (PPIs) and histamine H2 antagonists. Among children 12 months and older, studies have shown moderate benefit from PPIs and weak benefit from H2 antagonists for providing ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2015/0901/p351.html
Page 1